Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

JUAN CARLOS MOLINA

Allopathic & Osteopathic Physicians Family Medicine

NPI
1629179338
CMS profile
300904
Location
DALLAS, TX

General Payments · PY2018–2024

$10,281.22

  • Reported across 632 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$1,026.60

56 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $1,026.60 56

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Acerta Pharma LLC $203.91 13
Novo Nordisk AS $136.41 7
Boehringer Ingelheim Pharmaceuticals, Inc. $114.33 6
Amgen Inc. $103.45 5
GlaxoSmithKline, LLC. $91.76 5
PFIZER INC. $83.86 4
Indivior Inc. $56.95 3
Lilly USA, LLC $46.87 3
DEXCOM, INC. $39.36 2
ALK-Abello, Inc $35.75 2
Sumitomo Pharma America, Inc. $31.73 2
Braeburn Inc. $24.22 1
IDORSIA PHARMACEUTICALS US INC $22.96 1
Orexo US, Inc. $18.41 1
ABBVIE INC. $16.63 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $1,668.34 118
PY2019 $1,240.28 90
PY2020 $1,507.32 89
PY2021 $1,777.31 103
PY2022 $1,535.95 93
PY2023 $1,525.42 83
PY2024 $1,026.60 56

Payment records · PY2024 (56)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $16.63 04/30/2024 Food and Beverage Undisputed 01/23/2026 1105053960 CMS
ALK-Abello, Inc $15.66 06/17/2024 Food and Beverage Undisputed 01/23/2026 1099893371 CMS
ALK-Abello, Inc $20.09 07/25/2024 Food and Beverage Undisputed 01/23/2026 1099893373 CMS
Amgen Inc. $14.56 02/15/2024 Food and Beverage Undisputed 01/23/2026 1117330826 CMS
Amgen Inc. $21.29 04/17/2024 Food and Beverage Undisputed 01/23/2026 1117330828 CMS
Amgen Inc. $21.43 06/27/2024 Food and Beverage Undisputed 01/23/2026 1117330830 CMS
Amgen Inc. $17.44 08/19/2024 Food and Beverage Undisputed 01/23/2026 1117330832 CMS
Amgen Inc. $28.73 11/18/2024 Food and Beverage Undisputed 01/23/2026 1111654901 CMS
AstraZeneca Pharmaceuticals LP $14.38 02/14/2024 Food and Beverage Undisputed 01/23/2026 1104709139 CMS
AstraZeneca Pharmaceuticals LP $11.46 02/19/2024 Food and Beverage Undisputed 01/23/2026 1105876277 CMS
AstraZeneca Pharmaceuticals LP $20.95 03/18/2024 Food and Beverage Undisputed 01/23/2026 1104580384 CMS
AstraZeneca Pharmaceuticals LP $14.22 04/09/2024 Food and Beverage Undisputed 01/23/2026 1104492488 CMS
AstraZeneca Pharmaceuticals LP $13.37 04/24/2024 Food and Beverage Undisputed 01/23/2026 1105818923 CMS
AstraZeneca Pharmaceuticals LP $13.98 05/07/2024 Food and Beverage Undisputed 01/23/2026 1104670605 CMS
AstraZeneca Pharmaceuticals LP $14.39 06/04/2024 Food and Beverage Undisputed 01/23/2026 1104511132 CMS
AstraZeneca Pharmaceuticals LP $15.08 07/04/2024 Food and Beverage Undisputed 01/23/2026 1104427727 CMS
AstraZeneca Pharmaceuticals LP $15.57 07/11/2024 Food and Beverage Undisputed 01/23/2026 1105531204 CMS
AstraZeneca Pharmaceuticals LP $14.48 08/14/2024 Food and Beverage Undisputed 01/23/2026 1105861638 CMS
AstraZeneca Pharmaceuticals LP $20.74 10/02/2024 Food and Beverage Undisputed 01/23/2026 1104692988 CMS
AstraZeneca Pharmaceuticals LP $16.29 10/17/2024 Food and Beverage Undisputed 01/23/2026 1105576476 CMS
AstraZeneca Pharmaceuticals LP $19.00 12/06/2024 Food and Beverage Undisputed 01/23/2026 1104364807 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $13.07 01/31/2024 Food and Beverage Undisputed 01/23/2026 1118085786 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $22.35 02/22/2024 Food and Beverage Undisputed 01/23/2026 1118085794 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $16.96 03/13/2024 Food and Beverage Undisputed 01/23/2026 1118085790 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $23.67 07/02/2024 Food and Beverage Undisputed 01/23/2026 1118085796 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $21.89 08/07/2024 Food and Beverage Undisputed 01/23/2026 1118085792 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $16.39 10/15/2024 Food and Beverage Undisputed 01/23/2026 1118085788 CMS
Braeburn Inc. $24.22 02/13/2024 Food and Beverage Undisputed 01/23/2026 1125603733 CMS
Dexcom, Inc. $25.74 05/30/2024 Food and Beverage Undisputed 01/23/2026 1153311958 CMS
Dexcom, Inc. $13.62 11/08/2024 Food and Beverage Undisputed 01/23/2026 1153311960 CMS
GlaxoSmithKline, LLC. $18.98 02/02/2024 Food and Beverage Undisputed 01/23/2026 1116311311 CMS
GlaxoSmithKline, LLC. $18.10 02/07/2024 Food and Beverage Undisputed 01/23/2026 1116640204 CMS
GlaxoSmithKline, LLC. $18.37 05/29/2024 Food and Beverage Undisputed 01/23/2026 1116665695 CMS
GlaxoSmithKline, LLC. $18.21 07/24/2024 Food and Beverage Undisputed 01/23/2026 1116383646 CMS
GlaxoSmithKline, LLC. $18.10 12/09/2024 Food and Beverage Undisputed 01/23/2026 1116561238 CMS
IDORSIA PHARMACEUTICALS US INC $22.96 08/27/2024 Food and Beverage Undisputed 01/23/2026 1146789425 CMS
Indivior Inc. $20.79 02/29/2024 Food and Beverage Undisputed 01/23/2026 1144533777 CMS
Indivior Inc. $18.73 05/29/2024 Food and Beverage Undisputed 01/23/2026 1144533779 CMS
Indivior Inc. $17.43 12/19/2024 Food and Beverage Undisputed 01/23/2026 1144533781 CMS
Lilly USA, LLC $13.46 02/01/2024 Food and Beverage Undisputed 01/23/2026 1135087971 CMS
Lilly USA, LLC $15.98 02/21/2024 Food and Beverage Undisputed 01/23/2026 1135075069 CMS
Lilly USA, LLC $17.43 07/26/2024 Food and Beverage Undisputed 01/23/2026 1135111154 CMS
Novo Nordisk Inc $21.47 01/09/2024 Food and Beverage Undisputed 01/23/2026 1097508807 CMS
Novo Nordisk Inc $17.73 02/13/2024 Food and Beverage Undisputed 01/23/2026 1096868137 CMS
Novo Nordisk Inc $17.11 03/20/2024 Food and Beverage Undisputed 01/23/2026 1096915822 CMS
Novo Nordisk Inc $20.74 07/23/2024 Food and Beverage Undisputed 01/23/2026 1097288691 CMS
Novo Nordisk Inc $17.04 08/20/2024 Food and Beverage Undisputed 01/23/2026 1097476595 CMS
Novo Nordisk Inc $16.08 09/05/2024 Food and Beverage Undisputed 01/23/2026 1097439647 CMS
Novo Nordisk Inc $26.24 11/20/2024 Food and Beverage Undisputed 01/23/2026 1097456270 CMS
Orexo US, Inc. $18.41 03/05/2024 Food and Beverage Undisputed 01/23/2026 1136177496 CMS
PFIZER INC. $15.29 01/12/2024 Food and Beverage Undisputed 01/23/2026 1130987797 CMS
PFIZER INC. $21.01 02/05/2024 Food and Beverage Undisputed 01/23/2026 1132017632 CMS
PFIZER INC. $24.56 09/26/2024 Food and Beverage Undisputed 01/23/2026 1132040635 CMS
PFIZER INC. $23.00 09/30/2024 Food and Beverage Undisputed 01/23/2026 1132017658 CMS
Sumitomo Pharma America, Inc. $17.20 03/06/2024 Food and Beverage Undisputed 01/23/2026 1148892567 CMS
Sumitomo Pharma America, Inc. $14.53 11/13/2024 Food and Beverage Undisputed 01/23/2026 1148892569 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.